Aaron Gerlach, Ph.D., serves as our Director of Drug Discovery Alliances. He has been with Icagen since 2003, serving as a project lead for internal and collaborative research partnerships in addition to contributing to the development of Icagen’s business opportunities. Dr. Gerlach brings more than 25 years of ion channel target expertise and over 20 years in the neuroscience field. He serves on the scientific advisory board of the Pitt Hopkins Research Foundation, where he advises on research directed toward a treatment for this rare genetic form of autism. Dr. Gerlach received a doctorate from the University of Pittsburgh in Cell Biology and Physiology with subsequent postdoctoral training at the Vollum Institute at Oregon Health and Science University.